Skip to content

Single-center randomized controlled clinical study on the effectiveness of oral azithromycin in preventing perinatal infection in pregnant women with induced labor

Single-center randomized controlled clinical study on the effectiveness of oral azithromycin in preventing perinatal infection in pregnant women with induced labor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077629
Enrollment
Unknown
Registered
2023-11-14
Start date
2024-01-08
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perinatal infection

Interventions

Experimental group (oral azithromycin group):Azithromycin 2g was administered at the time of labor (at least 2cm dilation of the uterine opening)
Control group (blank group):No oral medication during labor

Sponsors

Drum Tower Hospital Affiliated to Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years old; 2. The gestation age is 37 weeks or more; 3. Singleton gestation; 4. No fever or other known infectious diseases; 5. Health care workers assess pregnant women who intend to use one or more methods of induction; 6. The patients who signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic to azithromycin or other macrolide antibiotics; 2. Use of azithromycin or other macrolide antibiotics within 3 days prior to randomization; 3. Planned cesarean section or full uterine opening before randomization; 4. Fetal death or known major congenital abnormalities; 5. Any disease that is considered contraindicated by a pregnant woman with a serious maternal disease or by an obstetrician (e.g. mental disorder, arrhythmia, structural heart disease, pulmonary edema, severe liver disease, kidney disease, etc.).

Design outcomes

Primary

MeasureTime frame
Rate of intrapartum infection and/or puerperal disease;

Secondary

MeasureTime frame
Delivery mode;Maternal complications;Neonatal complications;

Countries

China

Contacts

Public ContactDai Yimin

Drum Tower Hospital Affiliated to Nanjing University Medical School

nj_daiyimin@126.com+86 138 5149 2169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 18, 2026